CHA
ZOM

Carmichael Hill & Associates’s Zomedica Corp. ZOM Stock Holding History

Carmichael Hill & Associates’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,000
Closed -$147 – 818
2024
Q2 		$147 Buy
+1,000
New +$150 ﹤0.01% 765
2021
Q2 		– Sell
-200
Closed – – 804
2021
Q1 		$0 Buy
+200
New +$327 ﹤0.01% 793

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Carmichael Hill & Associates's ZOM Position: Q3 2024 in Review

Carmichael Hill & Associates sold out of Zomedica Corp. (ZOM) in Q3 2024, closing a stake of 1,000 shares — an estimated $147 sold.

Carmichael Hill & Associates first reported a position in ZOM in Q1 2021 and held it in 2 quarters. The position peaked at $147 in Q2 2024. 84 funds tracked by Wall St. Rank hold ZOM as of Q3 2024.

  • Carmichael Hill & Associates reported no remaining Zomedica Corp. position as of Q3 2024 after selling out during the quarter.
  • Carmichael Hill & Associates sold 1,000 Zomedica Corp. shares in Q3 2024, an estimated $147.
  • Carmichael Hill & Associates first reported a position in Zomedica Corp. in Q1 2021 and held it in 2 quarters.
  • Carmichael Hill & Associates's Zomedica Corp. position peaked at $147 in Q2 2024.
  • 84 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.